Clinical Evaluation of the Scopio Cell Morphology Technology

Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading of bone marrow aspirates. The aim of the current research will be the comparison between optical microscope reading and automatic pre-classification (AI based)

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Blood Cancer Hematologic Diseases Hematologic Neoplasms Hemic and Lymphatic Diseases Neoplasms Neoplasms by Site

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, 00168, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope

Exclusion criteria

Patients not affected by blood disorders
Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope

Treatment and study plan

Blood cells classification

Diagnostic Test

Comparison of the classification of peripheral blood and bone marrow cells with optical microscope reading with pre-classification using Scopio technology (AI based)

Primary outcomes

Optical microscope reading and automatic pre-classification

Time frame: 12 months

Comparison between optical microscope reading and automatic pre-classification (AI based)

Study contacts

Contact information is provided by the study sponsor or research team.

Elena Rossi, MD

CONTACT

[email protected]

+390630154206

Patrizia Chiusolo, MD

CONTACT

[email protected]

+390630154206

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

Clinical Evaluation of the Scopio Cell Morphology Technology on Pre-classification of Blood Cells in Peripheral Blood (PB) and Bone Marrow (BM)

Acronym: Hemascopio

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Aug 27, 2024
Registry last updated: Aug 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting